Rebamipide: evidence base for use in gastroenterology
Rebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most relevant clinical studies of rebamipide in diseases of various parts of the gastrointestinal tract, including the esophagus, stomach, small and larg...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2020-12-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/viewFile/60263/43430 |
_version_ | 1819119068490235904 |
---|---|
author | D. N. Andreev I. V. Maev |
author_facet | D. N. Andreev I. V. Maev |
author_sort | D. N. Andreev |
collection | DOAJ |
description | Rebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most relevant clinical studies of rebamipide in diseases of various parts of the gastrointestinal tract, including the esophagus, stomach, small and large intestine. |
first_indexed | 2024-12-22T05:58:54Z |
format | Article |
id | doaj.art-561d1730411f4d18816408b3c8dfa9c9 |
institution | Directory Open Access Journal |
issn | 0040-3660 2309-5342 |
language | Russian |
last_indexed | 2024-12-22T05:58:54Z |
publishDate | 2020-12-01 |
publisher | "Consilium Medicum" Publishing house |
record_format | Article |
series | Терапевтический архив |
spelling | doaj.art-561d1730411f4d18816408b3c8dfa9c92022-12-21T18:36:36Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422020-12-0192129710410.26442/00403660.2020.12.20045555198Rebamipide: evidence base for use in gastroenterologyD. N. Andreev0https://orcid.org/0000-0002-4007-7112I. V. Maev1https://orcid.org/0000-0001-6114-564XYevdokimov Moscow State University of Medicine and DentistryYevdokimov Moscow State University of Medicine and DentistryRebamipide is a cytoprotective drug that has been used in practical gastroenterology for 30 years. This article summarizes the main results of the most relevant clinical studies of rebamipide in diseases of various parts of the gastrointestinal tract, including the esophagus, stomach, small and large intestine.https://ter-arkhiv.ru/0040-3660/article/viewFile/60263/43430rebamipidegastroesophageal reflux diseasecorrosive esophagitisfunctional dyspepsiachronic gastritispeptic ulcer diseasehelicobacter pylorinsaid gastropathynsaid enteropathyulcerative colitis |
spellingShingle | D. N. Andreev I. V. Maev Rebamipide: evidence base for use in gastroenterology Терапевтический архив rebamipide gastroesophageal reflux disease corrosive esophagitis functional dyspepsia chronic gastritis peptic ulcer disease helicobacter pylori nsaid gastropathy nsaid enteropathy ulcerative colitis |
title | Rebamipide: evidence base for use in gastroenterology |
title_full | Rebamipide: evidence base for use in gastroenterology |
title_fullStr | Rebamipide: evidence base for use in gastroenterology |
title_full_unstemmed | Rebamipide: evidence base for use in gastroenterology |
title_short | Rebamipide: evidence base for use in gastroenterology |
title_sort | rebamipide evidence base for use in gastroenterology |
topic | rebamipide gastroesophageal reflux disease corrosive esophagitis functional dyspepsia chronic gastritis peptic ulcer disease helicobacter pylori nsaid gastropathy nsaid enteropathy ulcerative colitis |
url | https://ter-arkhiv.ru/0040-3660/article/viewFile/60263/43430 |
work_keys_str_mv | AT dnandreev rebamipideevidencebaseforuseingastroenterology AT ivmaev rebamipideevidencebaseforuseingastroenterology |